← Browse by Condition
Medical Condition

fallopian tube carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT07480954 Phase 1, Phase 2
Recruiting

Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16)

Enrollment
36 pts
Location
China
Sponsor
Beijing Biotech
View Trial →